Navigation Links
John C. Moran Named CEO at Core Essence Orthopaedics
Date:9/11/2009

YARDLEY, Pa., Sept. 11 /PRNewswire/ -- Core Essence Orthopaedics, Inc., a medical device company focused on soft tissue and skeletal repair of the extremities, announced today that John Moran will serve as Chief Executive Officer as well as Chairman of the Board, effective immediately.

"The addition of John as CEO will greatly benefit the company as it moves from product development to commercialization," said Zev Scherl, member of CE Ortho's Board of Directors and General Partner of NewSpring Capital. "John had tremendous success building a proprietary business during his time as President of Synthes Spine Inc.. In his new role as CEO of CE Ortho he now has a platform to build another highly attractive orthopaedic business."

"I look forward to leading CE Ortho as we begin to execute our sales strategy for our novel extremity products," stated John Moran. "The market opportunity for intuitive, arthroscopic devices in the extremity segment is substantial and to date the reception from surgeons has been very encouraging."

From 1990-1997, Moran founded and served as President of Synthes Spine, a division of Synthes (USA)--a global leader in orthopaedics. At Synthes Spine, Moran played an integral role in the design, manufacture and distribution of implants and instruments for spinal disorders. Moran has been an active angel investor in the medical device arena. He also currently serves on the boards of Power Medical Interventions, Paradigm Spine, and Ranier Technologies. Moran is a graduate of the University of Notre Dame and holds an MBA from Harvard University.

CE Ortho recently received FDA 510(k) clearance for SECURUS(TM), its innovative knotless suture anchor system for rotator cuff repair. SECURUS's intuitive design will allow easier and more certain fixation, along with superior tendon-to-bone footprint pressure to promote healing. SECURUS is specifically designed to give surgeons the motivation to make the transition to minimally invasive surgery at a time when the demand for arthroscopic surgery is greater than ever. The company is initiating sales for its various product lines over the next year.

About Core Essence Orthopaedics, Inc.

Core Essence Orthopaedics, Inc. (CE Ortho) is a privately held orthopaedic device company focused on the development, manufacturing and commercialization of solutions for minimally invasive soft tissue and arthroscopic musculoskeletal repair for the extremity market. CE Ortho's intuitive and innovative technologies are driven by increasing demands for alternatives to complicated surgical procedures. CE Ortho devices enable surgeons to build on classic and familiar surgical techniques with novel instruments and implants that simplify procedures and can be quickly mastered. The Company's proprietary technologies provide solutions to the growing volume of tendon and ligament repairs required by the active lifestyles of patients of all ages. For more company information, visit www.ceortho.com.

    Contact
    Alan Miller
    Executive VP Market and Business Development
    215.310.9534
    Alan.Miller@CEOrtho.com


'/>"/>
SOURCE Core Essence Orthopaedics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Campaign for Americas Future Memorandum: Katrina Storm Warning
2. Retired NYPD Lieutenants William E. Keegan, Jr., Owen McCaffery and John Moran and Tom Thees, a former COO in the financial industry, announce today the formation of H.E.A.R.T (Healing Emergency Aid Response Team) 911.
3. DuPont and TERI Sign Memorandum of Understanding on Green Building Design in India
4. Iraqs Ministry of Health and USAID Sign Memorandum of Understanding to Increase Cooperation in Public Management
5. Intercim and Dassault Systemes Sign Memorandum of Understanding
6. Anita Moran AIA Joins WHR Dallas
7. UCLA signs historic memorandum with pediatric institution in Tokyo
8. Statement on Presidential Memorandum to EPA to Review Lifting of Ban on California Clean Car Standard
9. John C. Moran Named Chairman of the Board at Core Essence Orthopaedics
10. The National Health Care Anti-Fraud Association Signs Memorandum of Understanding With Canadian and European Anti-Fraud Organizations
11. Heartline(R) Fitness Systems Named to Inc. Magazines Inaugural List of the 5000 Fastest Growing Private Companies in U.S....
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Grimsby, Ontario (PRWEB) , ... March 23, 2017 , ... The MBI “Hall of Fame” ... or whose acts have had a significant impact on the careers of all others involved. ... with NRB Inc. was inducted into the MBI’s Hall of Fame. The induction took ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... serving the families and businesses of the Norwalk and Vermillion areas, celebrates ... Recovery Center (N.O.R.A.) is a nonprofit, community-based substance abuse prevention and peer ...
(Date:3/23/2017)... ... 2017 , ... Benefits delivery trailblazer, Hodges-Mace, LLC, ... benefits dashboard solving one of the top frustrations in employee benefits – how ... time, employees can access up-to-date information and account balances for all of their ...
(Date:3/23/2017)... Angeles, CA (PRWEB) , ... March 23, 2017 ... ... A funding investment in Los Angeles based healthcare technology company California Healthcom Group ... portfolio into the US, and healthcare arena. With headquarters in California, CHG is ...
(Date:3/23/2017)... ... 23, 2017 , ... The TouchPoint Solution, home of Buzzies *, is ... anxiety. , “Buzzies change the way we interact with stress and live our ... its launch date in December 2016, The TouchPoint Solution has sold more than $750,000 ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... , March 23, 2017  The U.S. Food ... (avelumab) for the treatment of adults and pediatric patients ... (MCC), including those who have not received prior chemotherapy. ... a rare, aggressive form of skin cancer. ... cancers, patients with a rare form called Merkel cell ...
(Date:3/23/2017)... VANCOUVER, British Columbia , March 23, 2017 /PRNewswire/ ... "Company" or "Sophiris"), a clinical late-stage biopharmaceutical company developing ... announced that data from its successful Phase 2a study ... treatment for localized prostate cancer, will be presented as ... nd Annual European Association of Urology in ...
(Date:3/23/2017)... Research and Markets has announced the addition of the ... offering. ... global oxygen therapy devices market to grow at a CAGR of ... Oxygen Therapy Devices Market 2017-2021, has been prepared based on an ... the market landscape and its growth prospects over the coming years. ...
Breaking Medicine Technology: